MMGP and CHME my two holdings, both vastly undervalued.
CHME just announced earnings of a forward-looking net income of 59 cents for the year (and it's trading at only $2.60 right now, a PE of 4.5) and the sweetest part of it is, the CEO was pissed that it was wasn't much much higher! Whicb he says it will be next year ... the startup expenses for putting 160 NEW drugs on the Chinese market starting in 2008 held the net income below a buck. which it will climb above next year. It's a $10+ stock. Check it out for yourself.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.